Protagenic Therapeutics, Inc.\new (PTIX) › Shareholders' EquityProtagenic Therapeutics, Inc.\new (PTIX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: -$120.6K2014: -$121.4K2015: -$667.2K2016: $2.48M2017: $1.22M2018: -$210.9K2019: -$634.4K2020: -$1.15M2021: $9.94M2022: $6.92M2023: $3.67M2024: $1.01M$1.01M2013Shareholders' Equity (USD)2024Fiscal YearShareholders' EquityChange YoY2024$1.01M-72.4%2023$3.67M-47.0%2022$6.92M-30.4%2021$9.94M+964.7%2020-$1.15M-81.2%2019-$634.4K-200.8%2018-$210.9K-117.3%2017$1.22M-50.8%2016$2.48M+471.3%2015-$667.2K-449.8%2014-$121.4K-0.6%2013-$120.6K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share